In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0 a new company low.

Within Medical Laboratories industry 40 other companies have achieved higher Quick Ratio than Foxo Technologies Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 4579, from total ranking in the first quarter 2026 at 5405.

Explain Quick Ratio?
How much Cash & cash equivalents FOXO�s has?
What are FOXO�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

FOXO Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	23.45 %	10.14 %	-15.39 %	-5.54 %	54.41 %
Y / Y Cash & cash equivalent Change	-81.85 %	289.76 %	203.88 %	1748.7 %	875.12 %
Quick Ratio MRQ	0	0	0.01	0.02	0.01
FOXO's Total Ranking	# 4579	# 5405	# 5113	# 5334	# 5580
Seq. Current Liabilities Change	28.68 %	10.13 %	0.05 %	-12.93 %	14.8 %
Seq. Cash & cash equivalent Change	-11.36 %	-68.24 %	-67 %	95.33 %	1803.29 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 41
Healthcare Sector	# 928
Overall Market	# 4513

Quick Ratio Statistics
High	Average	Low
28.82	1.85	0
(Jun 30 2021)		(Mar 31 2025)

Financial Statements
Foxo Technologies Inc 's Current Liabilities	$ 41 Millions	Visit FOXO's Balance sheet
Foxo Technologies Inc 's Cash & cash equivalent	$ 0 Millions	Visit FOXO's Balance sheet
Source of FOXO's Sales		Visit FOXO's Sales by Geography

Cumulative Foxo Technologies Inc 's Quick Ratio

FOXO's Quick Ratio for the trailling 12 Months

FOXO Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	2.96 %	6.66 %	15.87 %	50.87 %	92.2 %
Y / Y Cash & cash equivalent TTM Growth	117.78 %	704.14 %	768.43 %	405.13 %	107.03 %
Quick Ratio TTM	0.01	0.01	0.01	0.01	0
Total Ranking TTM	# 3997	# 4641	# 3574	# 3705	# 3792
Seq. Current Liabilities TTM Growth	6.34 %	2.44 %	-4.2 %	-1.34 %	10.15 %
Seq. Cash & cash equivalent TTM Growth	-21.52 %	4.17 %	13.44 %	134.83 %	189.77 %

Quick ratio ranking by company, industry and sector >> Back to FOXO Financial Strength Comparisons >> Go to Compare FOXO Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the growth in Current Liabilities in the Q2 2026 to $40.62 millions, cumulative Quick Ratio remained unchanged at 0.01 below the Foxo Technologies Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 36 other companies have achieved higher Quick Ratio than Foxo Technologies Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 2961.

Explain Quick Ratio?
How much Cash & cash equivalents FOXO�s has?
What are FOXO�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 37
Healthcare Sector	# 914
Within the Market	# 4579

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.11	0.18	0
(Mar 31 2022)		(Mar 31 2025)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Laboratories Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Foxo Technologies Inc	0.00	$ 0.058 Millions	$ 40.615 Millions

Date modified: 2026-09-12T06:25:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.